Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

liquid biopsy

  • You have access
    Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation
    HIROAKI AKAMATSU, YUICHI OZAWA, JUN OYANAGI, DAICHI FUJIMOTO, AKITO HATA, NOBUYUKI KATAKAMI, KEISUKE TOMII, ERIKO MURAKAMI, TAKEYA SUGIMOTO, TOSHIO SHIMOKAWA, YASUHIRO KOH and NOBUYUKI YAMAMOTO
    Anticancer Research February 2021, 41 (2) 911-917; DOI: https://doi.org/10.21873/anticanres.14844
  • You have access
    The Expression Level of PD-L1 (CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer
    TAKAAKI MASUDA, MIWA NODA, AKIHIRO KITAGAWA, QINGJIANG HU, ATSUSHI FUJII, SHUHEI ITO, KEISUKE KOSAI, YUKI ANDO, YOSHIHIRO MATSUMOTO, HAJIME OHTSU, HIROKI UCHIDA, SHINJI OHNO and KOSHI MIMORI
    Anticancer Research July 2020, 40 (7) 3733-3742; DOI: https://doi.org/10.21873/anticanres.14362
  • You have access
    Clinical Utility of Combined Circulating Tumor Cell and Circulating Tumor DNA Assays for Diagnosis of Primary Lung Cancer
    SEONG MI MOON, JI-HO KIM, SEONG KEUN KIM, SEONWOO KIM, HYUK-JUNG KWON, JIN-SIK BAE, SUNGHOON LEE, HYE SEON LEE, MI-YOUNG CHOI, BYUNG HEE JEON, BYEONG-HO JEONG, KYUNGJONG LEE, HONG KWAN KIM, JHINGOOK KIM and SANG-WON UM
    Anticancer Research June 2020, 40 (6) 3435-3444; DOI: https://doi.org/10.21873/anticanres.14329
  • You have access
    Combinatory Analysis of Cell-free and Circulating Tumor Cell DNAs Provides More Variants for Cancer Treatment
    SUN-YOUNG LEE, DONG-KYU CHAE, JAHYUN AN, SEOKCHAN YOO, SUNGMOK JUNG, CHANG HOON CHAE, JONG BHAK, BYUNG CHUL KIM and DONG-HYU CHO
    Anticancer Research December 2019, 39 (12) 6595-6602; DOI: https://doi.org/10.21873/anticanres.13875
  • You have access
    Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case
    KAISA I. LEHTOMAKI, LAURA I. LAHTINEN, NINA RINTANEN, TEIJO KUOPIO, IVANA KHOLOVA, RAMI MAKELA, JUHA K. RANTALA, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and JUHA KONONEN
    Anticancer Research November 2019, 39 (11) 5867-5877; DOI: https://doi.org/10.21873/anticanres.13791
  • You have access
    Seminal Cell Free DNA Concentration Levels Discriminate Between Prostate Cancer and Benign Prostatic Hyperplasia
    GIOVANNI PONTI, MONIA MACCAFERRI, SALVATORE MICALI, MARCO MANFREDINI, RICCARDO MILANDRI, GIAMPAOLO BIANCHI, GIOVANNI PELLACANI, SHANIKO KALECI, JOHANNA CHESTER, ANDREA CONTI, CHIARA DEL PRETE and ALDO TOMASI
    Anticancer Research September 2018, 38 (9) 5121-5125; DOI: https://doi.org/10.21873/anticanres.12833
  • You have access
    Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer
    TAKAAKI MASUDA, YOSHIAKI SHINDEN, MIWA NODA, HIROKI UEO, QINGJIANG HU, YUKIHIRO YOSHIKAWA, YUSUKE TSURUDA, YOSUKE KURODA, SHUHEI ITO, HIDETOSHI EGUCHI, SHINJI OHNO and KOSHI MIMORI
    Anticancer Research August 2018, 38 (8) 4515-4523; DOI: https://doi.org/10.21873/anticanres.12755
  • You have access
    Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy
    KAZUTOSHI KOMIYA, CHIHO NAKASHIMA, TOMOMI NAKAMURA, HARUKI HIRAKAWA, TOMONORI ABE, SHINSUKE OGUSU, KOICHIRO TAKAHASHI, YUJI TAKEDA, YOSHIAKI EGASHIRA, SHINYA KIMURA and NAOKO SUEOKA-ARAGANE
    Anticancer Research June 2018, 38 (6) 3559-3566; DOI: https://doi.org/10.21873/anticanres.12628
  • You have access
    Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer
    LILITE SADOVSKA, JĀNIS EGLĪTIS and AIJA LINĒ
    Anticancer Research December 2015, 35 (12) 6379-6390;

Pages

  • Previous
  • 1
  • 2
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire